M ost if not all polypeptide hormones are synthesized from large precursors that contain NH 2 -terminal peptide extensions termed leader or signal sequences. This has been shown by analyses
both of the products synthesized early during pulse chase labeling studies 1 -2 and of products resulting from cell-free translations of mRNAs coding for a number of different polypeptide hormones. 3 " 6 When the cell-free translation systems are supplemented with microsomal membranes, the leader sequences are removed cotranslationally during the transport of the nascent polypeptides across the membrane bilayer. 7 - 8 In some instances the polypeptides remaining after removal of the leader sequences are further processed cotranslationally by glycosylation and/or posttranslationally by additional cleavages. 9 It is generally believed that these coand posttranslation processes subserve important functions in the cellular transport and formation of biologically active hormones.
The pancreatic islets produce several small polypeptide hormones: insulin (mol. wt. = 6000), glucagon (mol. wt. = 3500), somatostatin (mol. wt. = 1600), and pancreatic polypeptide (mol. wt. = 4200).
10>11 Cell-free synthesis of preproinsulin, a precursor of insulin, and the further processing steps in the formation of insulin have been described. 3 -12 However, the biosynthetic pathways involved in the formation of glucagon are not well understood. Pulse-chase studies with labeled amino acids and intact islet cells have indicated the existence of higher molecular weight forms of glucagon, 12 " 14 but identification and characterization of the products of cell-free translations of the mRNA coding for glucagon have not been described.
In this report we describe the identification of biosynthetic precursors to pancreatic glucagon by analyses of the products of cell-free translation of mRNA prepared from anglerfish islets.
MATERIALS AND METHODS
Preparation of RNA. Islet tissue was obtained fresh from the anglerfish (Lophius americanus) and was immediately frozen in liquid nitrogen. Polyadenylated RNA was isolated from the islet tissue by the methods of Kronenberg et al. 15 and Majzoub et al. 16 Approximately 100 /xg (2.0 A 260 U) of polyadenylated RNA was obtained from 10 g of islet tissue. Cell-free translations. A heterologous cell-free translation system was prepared from an extract of wheat germ.
17 RNA (0.5-1.0 /xg) dissolved in sterile H 2 O was translated in reaction mixtures of 25-100 /ul, which contained L-[ 35 S]methionine (800-1000 Ci/mmol, 4 mCi/m, New England Nuclear, Boston, Massachusetts). After 3 h of incubation at 20°C, translation reaction mixtures were either adjusted to 0.05 M Tris-HCI, pH 7.0, 1% SDS, 1% /3-mercaptoethanol, 10% glycerol, and 0.01% bromophenol blue (sample electrophoresis buffer) in preparation for electrophoretic analysis, or were frozen at -20°C for subsequent use in immunoprecipitation studies. Stimulation of protein synthesis in the cell-free system was determined by precipitation of labeled translation products with 10% tricholoroacetic acid. Radioactivity in the precipitates was measured by liquid scintillation spectroscopy. Membrane processing. Microsomal membranes were prepared from a fresh canine pancreas by the method of Katz et al. 18 In experiments that involved processing of translation products, 1 (x\ (115 A 250 U/ml) of a suspension of membranes was added directly to the translation mixtures (25 /JL\) before the addition of RNA. Proteolysis of membrane-processed translation products. Aliquots of cell-free translations with added microsomal membranes were incubated with a mixture of chymotrypsin and trypsin (final concentration of both enzymes 50 /xg/ml) for 60 min at 0°C. Duplicate reaction tubes were set up: to one Triton X-100 was added to give a final concentration of 1% before addition of proteases; to the other was added an equal volume of water. Proteolysis was terminated by addition of Trasylol to give a final concentration of 1000 U/ml. Reaction mixtures were used in subsequent immunoprecipitation studies or were added to sample electrophoresis buffer and incubated at 100°C for 2 min in preparation for gel electrophoresis. Immunoprecipitations. Immunoprecipitations were performed with a double antibody procedure. Routinely, 5 /ul of the labeled translation mixture was added to 100 fi\ of Trisbuffered saline, pH 7.4 (20 mM Tris, 0.15 M NaCI), which contained 1% Triton X-100, 0.5% human serum albumin, and 10 U Trasylol. Samples were then centrifuged at 4°C for 15 min at 10,000 rpm. The supematants were incubated overnight at 4°C with 1 fi\ of undiluted rabbit antiserum prepared against natural porcine glucagon, or with 1 /al of nonimmune rabbit serum. The glucagon antiserum, R 32, used in this study shows specificity for the N-terminus region of pancreatic glucagon and cross-reacts equally on a molar basis with natural porcine pancreatic glucagon and with natural porcine glicentin (Dr. David Sanders, Newcastleupon-Tyne, personal communication). To test the specificity of antibody binding, selected samples were also treated with 10 ju,g of unlabeled highly purified porcine pancreatic glucagon (Novo Ltd., Copenhagen, Denmark) before addition of glucagon antiserum. After the first antibody incubation, 10 (A\ of goat antirabbit gamma globulin was added to each tube and samples were incubated for an additional 18 h at 4°C. The resultant immunoprecipitates were collected by centrifugation at 10,000 rpm for 60 min at 4°C through 1 ml of 1 M sucrose in Tris-buffered saline, pH 7.4, which contained 1% Triton X-100 and 1% Na deoxycholate. The immunoprecipitates were then successively washed with 1 ml of 0.1 M Na acetate, pH 4.6; 0.1 M Na borate, pH 8.8; and Tris-buffered saline, pH 7.4. The immunoprecipitates were dissolved in sample electrophoresis buffer by heating at 37°C for 1 h followed by incubation at 100°C for 2 min. SDS-polyacrylamide gel electrophoresis. Translation products and immunoprecipitates were analyzed by electrophoresis on 12.5%-20% gradient polyacrylamide gel slabs, which contained 0.1% SDS. 19 Molecular weight markers were subjected to electrophoresis in adjacent wells of the gels. Gel slabs were stained in 0.2% coomassie brilliant blue, destained in 25% methanol, 7% acetic acid, and then treated with Enhance (Mew England Nuclear, Boston, Massachusetts). Autoradiofluorograms were prepared by exposure of the vacuum-dried gels to Kodak SB-5 film for periods of 3-24 h.
RESULTS
Polyadenylated RNA prepared from anglerfish islet tissue stimulated protein synthesis in the wheat germ cell-free system by 170-fold in the absence of microsomal membranes and 70-fold in the presence of microsomal membranes, compared with control translations without added RNA. By electrophoretic analysis on SDS polyacrylamide gels the RNA was shown to direct synthesis of five major proteins with apparent molecular weights ranging between 16,000 and 11,000 ( Figure 1, lane B) . Inclusion of microsomal membranes in the translation reactions resulted in the appearance of two additional discernible products with apparent molecular weights of 13,500 and 9000 ( Figure 1 , lane A), and there was a concomitant reduction in intensity of three of the bands observed in translations without inclusion of microsomal membranes (Figure 1, lane B) . These results indicate that at least three of the protein products undergo processing as a result of the addition of microsomal membranes to the translation reactions.
Two proteins (M r = 14,500 and M r = 12,500) produced in translations without added microsomal membranes were immunoprecipitated with an antiserum raised to porcine glucagon, and in addition a minor labeled protein of M r = 12,000 appeared in the immunoprecipitate (Figure 1 , lane C). Addition of unlabeled glucagon inhibited the immunoprecipitation of the radioactive translation products ( Figure  1, lane D) , and the products were not seen in immunoprecipitates obtained with nonimmune serum (Figure 1 , lane E). These observations suggest either that the islet mRNA directs synthesis of two separate glucagon-related precursors or that the 12,500 M r protein is produced by processing of the 14,500 M r protein by intrinsic enzymic activity within the wheat germ extract.
To further investigate these two possibilities we analyzed immunoprecipitates prepared from labeled products of translations with added microsomal membranes. Antiserum to glucagon specifically immunoprecipitated only a single labeled protein of M r = 12,500, which was identical in electrophoretic mobility to the smaller of the two immunoreactive proteins observed in translations without added microsomal membranes ( Figure 2 , lane E). We obtained additional evidence that the protein of M r = 12,500 is a processed form of the 14,500 M r translation product when the products of translations with added microsomal membranes were subjected to limited proteolysis by incubation with chymotrypsin and trypsin. Four discernible products were resistant to proteolytic degradation (Figure 2, lane C) , a finding indicative of the segregation of these translation products within microsomal vesicles during their cotranslational pro- cessing. 7 These products were hydrolyzed when the translation mixture was treated with Triton X-100 before addition of enzymes ( Figure 2, lane A) , a procedure that lyses microsomai vesicles and renders their contents susceptible to proteolysis. 7 One of the membrane processed products that was resistant to proteolysis comigrated with the 12,500 M r glucagon-related protein (Figure 2 , lanes C and E) and was specifically immunoprecipitated by an antiserum to glucagon (Figure 2, lane D) .
Note that in spite of extensive washing of the immunoprecipitation, traces of labeled pre-proinsulin (PPI) and proinsulin (PI) remained adsorbed to immunoprecipitated material (Figures 1 and 2 ).
DISCUSSION
Our findings that polyadenylated RNA extracted from anglerfish islets directs the synthesis of five major protein products of M r between 16,000 and 11,000 are in agreement with the previous findings of Shields and Blobel. 3 These workers showed that the smallest of the translation products is a biosynthetic precursor of insulin, pre-proinsulin. It seemed likely to us that one or more of the other translation products correspond to a biosynthetic precursor of glucagon inasmuch as this hormone has been identified as a prominent product in anglerfish islets by immunocytochemical and radioimmunoassay studies. We demonstrated that two cell-free translation products (M r = 14,500 and M r = 12,500) were related to glucagon by their specific immunoprecipitation with an antiserum to glucagon and that inclusion of microsomal membranes in the translation reactions resulted in a decrease in the 14,500 M r protein and a marked increase in the 12,500 M r protein. Furthermore, the smaller (but not the larger) protein was resistant to limited proteolysis. It has been shown previously that in cell-free systems microsomal membranes process secretory proteins cotranslationally by removal of leader sequences from the nascent proteins, concomitant with sequestration of the protein within microsomal vesicles where they are resistant to limited proteolysis. 3 -7 - 8 We propose, therefore, that the 12,500 M r protein is a processed form of the 14,500 M r protein and by comparison with known biosynthetic pathways for other peptide hormones 3 " 6 that the 14,500 M r and 12,500 M r proteins should be designated pre-proglucagon and proglucagon, respectively. It appears that the small amount of the 12,500 M r protein seen in the products of the translations in which no microsomal membranes were added results from partial processing of the 14,500 M r protein by enzymic activities in the wheat germ cell-free system. We have also observed such processing of pre-prosomatostatin.
20
A larger form of glucagon, glicentin, known to contain the amino acid sequence of pancreatic glucagon, 21 ' 22 has been identified in pig intestine 21 ' 22 and human islets.
23 Glicentin (M r = 12,000) and pancreatic glucagon (M r = 3,500) may arise from a common biosynthetic precursor by way of different posttranslational enzymic cleavages. 14 - 21 Thus, it is possible that the glucagon precursor that we have identified in these studies contains amino acid sequences found in glicentin, inasmuch as the antiserum to glucagon that we used recognizes both pancreatic glucagon and glicentin.
The islet mRNA coding for the precursor of glucagon will prove useful for the preparation of cDNA and the subsequent construction and molecular cloning of recombinant DNA molecules containing the nucleic acid sequence coding for the glucagon precursor. The use of recombinant DNA technology to investigate the amino acid sequence of the glucagon precursor may establish whether the amino acid sequence to glicentin resides in the precursor to pancreatic glucagon.
